{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_024415.3:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_024415.3",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "V",
            "alt": "M",
            "position": "2009"
          },
          "Description in input context": "c.6055G>A (p.V2009M)"
        },
        {
          "HGVS": "NM_024415.3:c.6070T>C",
          "cDNA Change": {
            "transcript": "NM_024415.3",
            "ref": "T",
            "alt": "C",
            "position": "6070"
          },
          "Protein Change": {
            "ref": "S",
            "alt": "P",
            "position": "2021"
          },
          "Description in input context": "c.6070T>C (p.S2021P)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0010867"
  },
  "Experiment Method": [
    {
      "Assay Method": "Kinase activity assay",
      "Material used": {
        "Material Source": "Cell line/In vitro model",
        "Material Name": "N.D.",
        "Description": "The experiment was conducted using a cell line/in vitro model."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_024415.3:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Kinase activity was reduced by 30% for the variant NM_024415.3:c.6055G>A."
        },
        {
          "Variant": "NM_024415.3:c.6070T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "Kinase activity was reduced by 20% for the variant NM_024415.3:c.6070T>C."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity greater than 80%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity less than 50%.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}